What is Novo-Nordisk A/S's Market Cap?

Novo-Nordisk A/S's Market Cap is $172.3B, based on as-reported figures from SEC (XBRL) filings.

What is Novo-Nordisk A/S's Enterprise Value?

Novo-Nordisk A/S's Enterprise Value is $190.6B, based on as-reported figures from SEC (XBRL) filings.

What is Novo-Nordisk A/S's Trailing P/E?

Novo-Nordisk A/S's Trailing P/E is 10.7×, based on as-reported figures from SEC (XBRL) filings.

What is Novo-Nordisk A/S's Price / Sales?

Novo-Nordisk A/S's Price / Sales is 3.5×, based on as-reported figures from SEC (XBRL) filings.

What is Novo-Nordisk A/S's EV / Revenue?

Novo-Nordisk A/S's EV / Revenue is 3.9×, based on as-reported figures from SEC (XBRL) filings.

What is Novo-Nordisk A/S's EV / EBITDA?

Novo-Nordisk A/S's EV / EBITDA is 8.4×, based on as-reported figures from SEC (XBRL) filings.

What is Novo-Nordisk A/S's Revenue (TTM)?

Novo-Nordisk A/S's Revenue (TTM) is $48.6B, based on as-reported figures from SEC (XBRL) filings.

What is Novo-Nordisk A/S's Net Income (TTM)?

Novo-Nordisk A/S's Net Income (TTM) is $16.1B, based on as-reported figures from SEC (XBRL) filings.

What is Novo-Nordisk A/S's EBITDA?

Novo-Nordisk A/S's EBITDA is $22.4B, based on as-reported figures from SEC (XBRL) filings.

What is Novo-Nordisk A/S's Diluted EPS (TTM)?

Novo-Nordisk A/S's Diluted EPS (TTM) is 3.60, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Novo-Nordisk A/S

XNYS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S5TSK0

38.58▼ 0.06 (-0.16%)

As of 2026-10-12

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 38.64
Day's Range: 38.26 – 38.85
52-Week Range: 35.12 – 64.17
Volume: 8.3M
Avg Volume: 12.7M

Share Statistics

Shares Outstanding
Employees: 69.5K
Exchange: XNYS
Listed: 1981-04-30

Share count as of December 31, 2025

Novo-Nordisk A/S (NVO) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Novo-Nordisk A/S (NVO)

What is Novo-Nordisk A/S's Market Cap?: Novo-Nordisk A/S's Market Cap is $172.3B, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's Enterprise Value?: Novo-Nordisk A/S's Enterprise Value is $190.6B, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's Trailing P/E?: Novo-Nordisk A/S's Trailing P/E is 10.7×, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's Price / Sales?: Novo-Nordisk A/S's Price / Sales is 3.5×, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's EV / Revenue?: Novo-Nordisk A/S's EV / Revenue is 3.9×, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's EV / EBITDA?: Novo-Nordisk A/S's EV / EBITDA is 8.4×, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's Revenue (TTM)?: Novo-Nordisk A/S's Revenue (TTM) is $48.6B, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's Net Income (TTM)?: Novo-Nordisk A/S's Net Income (TTM) is $16.1B, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's EBITDA?: Novo-Nordisk A/S's EBITDA is $22.4B, based on as-reported figures from SEC (XBRL) filings.
What is Novo-Nordisk A/S's Diluted EPS (TTM)?: Novo-Nordisk A/S's Diluted EPS (TTM) is 3.60, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · NVOAs-filed SEC (XBRL) data